Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 45192

1.

Ustekinumab: a novel therapeutic option in Crohn's disease.

Simon EG, Samuel S, Ghosh S, Moran GW.

Expert Opin Biol Ther. 2016 Jun 24. [Epub ahead of print]

PMID:
27341173
2.

Employment status, difficulties at work and quality of life in inflammatory bowel disease patients.

De Boer AG, Bennebroek Evertsz' F, Stokkers PC, Bockting CL, Sanderman R, Hommes DW, Sprangers MA, Frings-Dresen MH.

Eur J Gastroenterol Hepatol. 2016 Jun 23. [Epub ahead of print]

PMID:
27340897
3.

Circulating Bone Marrow-Derived CD45-/CD34+/CD133+/VEGF+ Endothelial Progenitor Cells in Adults with Crohn's Disease.

Boltin D, Kamenetsky Z, Perets TT, Snir Y, Sapoznikov B, Schmilovitz-Weiss H, Ablin JN, Dickman R, Niv Y.

Dig Dis Sci. 2016 Jun 23. [Epub ahead of print]

PMID:
27339637
4.

Campylobacter concisus utilizes blood but not short chain fatty acids despite showing associations with Firmicutes taxa.

Kaakoush NO, Thomas DS, Ruzayqat MM, Lynch D, Leach ST, Lemberg DA, Day AS, Mitchell HM.

Microbiology. 2016 Jun 23. doi: 10.1099/mic.0.000328. [Epub ahead of print]

PMID:
27339421
5.

Evolving roles of cross-sectional imaging in Crohn's disease.

Magarotto A, Orlando S, Coletta M, Conte D, Fraquelli M, Caprioli F.

Dig Liver Dis. 2016 May 30. pii: S1590-8658(16)30434-0. doi: 10.1016/j.dld.2016.05.017. [Epub ahead of print] Review.

PMID:
27338853
6.

Prevalence and associated factors of abnormal liver values in children with celiac disease.

Äärelä L, Nurminen S, Kivelä L, Huhtala H, Mäki M, Viitasalo A, Kaukinen K, Lakka T, Kurppa K.

Dig Liver Dis. 2016 Jun 2. pii: S1590-8658(16)30458-3. doi: 10.1016/j.dld.2016.05.022. [Epub ahead of print]

PMID:
27338852
7.

An activating gucy2c mutation causes impaired contractility and fluid stagnation in the small bowel.

von Volkmann HL, Nylund K, Tronstad RR, Hovdenak N, Hausken T, Fiskerstrand T, Gilja OH.

Scand J Gastroenterol. 2016 Jun 24:1-8. [Epub ahead of print]

PMID:
27338166
8.

Blood and Intestine eQTLs from an Anti-TNF-Resistant Crohn's Disease Cohort Inform IBD Genetic Association Loci.

Di Narzo AF, Peters LA, Argmann C, Stojmirovic A, Perrigoue J, Li K, Telesco S, Kidd B, Walker J, Dudley J, Cho J, Schadt EE, Kasarskis A, Curran M, Dobrin R, Hao K.

Clin Transl Gastroenterol. 2016 Jun 23;7(6):e177. doi: 10.1038/ctg.2016.34.

PMID:
27336838
9.

NOD2 induces autophagy to control AIEC bacteria infectiveness in intestinal epithelial cells.

Negroni A, Colantoni E, Vitali R, Palone F, Pierdomenico M, Costanzo M, Cesi V, Cucchiara S, Stronati L.

Inflamm Res. 2016 Jun 22. [Epub ahead of print]

PMID:
27335178
10.

Minimal-invasive approach for penetrating Crohn's disease is not associated with increased complications.

Kristo I, Stift A, Argeny S, Mittlböck M, Riss S.

Surg Endosc. 2016 Jun 22. [Epub ahead of print]

PMID:
27334961
11.

Facilitation of Endosomal Recycling by an IRG Protein Homologue Maintains Apical Tubule Structure in Caenorhabditis elegans.

Grussendorf KA, Trezza CJ, Salem AT, Al-Hashimi H, Mattingly BC, Kampmeyer DE, Khan L, Hall DH, Göbel V, Ackley BD, Buechner M.

Genetics. 2016 Jun 22. pii: genetics.116.192559. [Epub ahead of print]

12.

Coexistence of eating disorders and autoimmune diseases: record linkage cohort study, uk.

Wotton CJ, James A, Goldacre MJ.

Int J Eat Disord. 2016 Jun 23. doi: 10.1002/eat.22544. [Epub ahead of print]

PMID:
27333941
13.

AN EPIDEMIOLOGICAL STUDY OF THIOPURINE-METHYLTRANSFERASE VARIANTS IN A CROATIAN INFLAMMATORY BOWEL DISEASE PATIENT COHORT.

Ladić A, Božina N, Borzan V, Brinar M, Vucelić B, Cuković-Cavka S.

Acta Clin Croat. 2016 Mar;55(1):16-22.

PMID:
27333713
14.

Eosinophilic Esophagitis: Impact of Latest Insights Into Pathophysiology on Therapeutic Strategies.

Schoepfer A, Safroneeva E, Straumann A.

Dig Dis. 2016 Jun 22;34(5):462-468. [Epub ahead of print]

PMID:
27333298
15.

Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel Diseases.

Atreya R, Neurath MF.

Dig Dis. 2016 Jun 22;34(5):552-557. [Epub ahead of print]

PMID:
27333283
16.

Colitis as the Sole Initial Presentation of Chronic Granulomatous Disease: Histopathologic Clues to Diagnosis.

Rosenbaum BE, Shenoy R, Vuppula S, Thomas K, Moy L, Kaul A.

Pediatr Infect Dis J. 2016 Jun 21. [Epub ahead of print]

PMID:
27331854
17.

Microbiota as Therapeutic Targets.

Xavier RJ.

Dig Dis. 2016 Jun 22;34(5):558-565. [Epub ahead of print]

PMID:
27331403
18.

Acquired vulvar lymphangioma circumscriptum after cervical cancer treatment: Case report.

Valente K, Montgomery K, Schultenover S, Desouki MM.

Gynecol Oncol Rep. 2016 Apr 1;16:31-3. doi: 10.1016/j.gore.2016.03.006. eCollection 2016 Apr.

19.

What to Do When Biologic Agents Are Not Working in Inflammatory Bowel Disease Patients.

Dalal SR, Cohen RD.

Gastroenterol Hepatol (N Y). 2015 Oct;11(10):657-65.

20.

Autoimmune gastrointestinal complications in patients with systemic lupus erythematosus: case series and literature review.

Alves SC, Fasano S, Isenberg DA.

Lupus. 2016 Jun 20. pii: 0961203316655210. [Epub ahead of print] Review.

PMID:
27329649
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk